State Street
BCAB icon

State Street’s BioAtla BCAB Stock Holding History

State Street’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.4K Hold
3,028
– – ﹤0.01% 4204
2025
Q4 		$85.9K Hold
3,028
– – ﹤0.01% 4070
2025
Q3 		$104K Hold
3,028
– – ﹤0.01% 4046
2025
Q2 		$59.9K Hold
3,028
– – ﹤0.01% 4064
2025
Q1 		$52.5K Hold
3,028
– – ﹤0.01% 4089
2024
Q4 		$89.5K Buy
3,028
+236
+8% +$19.8K ﹤0.01% 4009
2024
Q3 		$246K Hold
2,792
– – ﹤0.01% 3781
2024
Q2 		$191K Sell
2,792
-13,034
-82% -$1.55M ﹤0.01% 3836
2024
Q1 		$2.72M Buy
15,826
+1,339
+9% +$166K ﹤0.01% 3174
2023
Q4 		$1.78M Hold
14,487
– – ﹤0.01% 3349
2023
Q3 		$1.23M Buy
14,487
+242
+2% +$30.8K ﹤0.01% 3474
2023
Q2 		$2.14M Buy
14,245
+11,581
+435% +$1.99M ﹤0.01% 3385
2023
Q1 		$357K Buy
2,664
+272
+11% +$49K ﹤0.01% 3861
2022
Q4 		$987K Buy
2,392
+800
+50% +$332K ﹤0.01% 3560
2022
Q3 		$613K Buy
1,592
+472
+42% +$155K ﹤0.01% 3699
2022
Q2 		$160K Sell
1,120
-4,579
-80% -$729K ﹤0.01% 4305
2022
Q1 		$1.43M Sell
5,699
-16,839
-75% -$7.04M ﹤0.01% 3689
2021
Q4 		$22.1M Buy
22,538
+3,663
+19% +$4.69M ﹤0.01% 2408
2021
Q3 		$27.8M Buy
18,875
+5,926
+46% +$11.5M ﹤0.01% 2239
2021
Q2 		$27.4M Buy
12,949
+9,547
+281% +$21.6M ﹤0.01% 2300
2021
Q1 		$8.65M Buy
+3,402
New +$8.72M ﹤0.01% 2802

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street's BCAB Position: Q1 2026 in Review

State Street held its BioAtla (BCAB) position steady in Q1 2026 at 3,028 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4204.

State Street first reported a position in BCAB in Q1 2021 and has held it in 21 quarters since. The position peaked at $27.8M in Q3 2021. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • State Street held 3,028 shares of BioAtla worth $24.4K as of Q1 2026.
  • State Street left its BioAtla share count unchanged in Q1 2026.
  • BioAtla made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4204 holding.
  • State Street first reported a position in BioAtla in Q1 2021 and has held it in 21 quarters since.
  • State Street's BioAtla position peaked at $27.8M in Q3 2021.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.